Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Immunome Q2 Earnings

Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Immunome beat estimated earnings by 1.33%, reporting an EPS of $-0.74 versus an estimate of $-0.75.
byBenzinga Insights
August 5, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Immunome beat estimated earnings by 1.33%, reporting an EPS of $-0.74 versus an estimate of $-0.75.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.27 which was followed by a 11.81% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Immunome visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview: Bank of Montreal

By Benzinga Insights
August 29, 10:16 AM
Bank of Montreal (NYSE:BMO) is set to give its latest quarterly earnings report on Tuesday, 2022-08-30. Here's what investors need to know before the announcement. Analysts estimate that Bank of Montreal will report an earnings per share (EPS) of $2.39.

BMO